Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein for cardiometabolic dysfunction in prostate cancer
NCT02766478Phase 2Terminated
- Sponsor
- Emory University
- Start
- Oct 2017
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of genistein in prostate cancer (PCa), sponsored by Emory University. Started Oct 2017; status: terminated.
02
Drugs
genistein
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02766478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02766478.